JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa.

MLA

Boor, Patrick P. C., et al. “JAK-Inhibitor Tofacitinib Suppresses Interferon Alfa Production by Plasmacytoid Dendritic Cells and Inhibits Arthrogenic and Antiviral Effects of Interferon Alfa.” Translational Research : The Journal of Laboratory and Clinical Medicine, vol. 188, Oct. 2017, pp. 67–79. EBSCOhost, https://doi.org/10.1016/j.trsl.2016.11.006.

APA

Boor, P. P. C., de Ruiter, P. E., Asmawidjaja, P. S., Lubberts, E., van der Laan, L. J. W., & Kwekkeboom, J. (2017). JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. Translational Research : The Journal of Laboratory and Clinical Medicine, 188, 67–79. https://doi.org/10.1016/j.trsl.2016.11.006

Chicago

Boor, Patrick P C, Petra E de Ruiter, Patrick S Asmawidjaja, Erik Lubberts, Luc J W van der Laan, and Jaap Kwekkeboom. 2017. “JAK-Inhibitor Tofacitinib Suppresses Interferon Alfa Production by Plasmacytoid Dendritic Cells and Inhibits Arthrogenic and Antiviral Effects of Interferon Alfa.” Translational Research : The Journal of Laboratory and Clinical Medicine 188 (October): 67–79. doi:10.1016/j.trsl.2016.11.006.